Dr. Lin, Yi-Ling ’s Lab林宜玲 博士 實驗室


Our laboratory centers on three important emerging/reemerging flaviviruses, namely Japanese encephalitis virus (JEV), dengue virus (DENV) and Zika virus (ZIKV). JEV is transmitted to humans by infected mosquitoes and causes acute encephalitis with high fatality rates. DENV generally causes a mild febrile illness called dengue fever and infrequently much more severe diseases, such as dengue hemorrhagic fever and dengue shock syndrome. ZIKV infection displays nonspecific clinical features and generally causes mild symptoms in humans. However, the recent ZIKV outbreak in Brazil has created a public health emergency of international concern. Although case fatality of ZIKV is low, maternal infection during pregnancy has been linked to congenital microcephaly. The flavivirus genome is a single-stranded, positive-sense RNA, which contains a single open reading frame encoding a polyprotein. In the infected cells this polyprotein is proteolytically cleaved into at least 11 viral structural and nonstructural proteins. Research interests in this laboratory are the molecular biology, virology, and pathogenesis mechanisms of these viruses. Our overall goal is to understand the multifaceted virus-host interactions in JEV, DENV and ZIKV infection.

There have been several dengue endemics in southern Taiwan in these years. Plus the 2003 SARS and 2015-2016 ZIKV outbreaks, these living lessons have prompted us not only to focus on basic virology research, but also to think deeply about how to deal with emerging viral infections. As a lab working on viral research, we understand the threat of an emerging infectious disease and the importance of rapid response. How can we act quickly when an epidemic occurs and do something to help the control of an outbreak have become important issues in our mindset. In respond to the COVID-19 outbreak, Academia Sinica formed a task force on Jan 28, 2020 and Dr. Yi-Ling Lin has been the coordinator of the task force. Dr. Lin is in charge of the P3 facility in IBMS and also the CEO of the newly established “Emerging Infectious Disease Division (EIDD)” in Biomedical Translation Research Center (BioTReC) located in the National Biotechnology Research Park, Nangang, Taipei. Thus, besides working on flaviviruses, our lab has also being working on SARS-CoV-2 since 2020. We have established reagents and assay systems to serve the urgent needs of testing research materials developed to fight against COVID-19.

Overall, we have chances to work with researchers inside and outside Academia Sinica, as well as commercial drug/vaccine developers on this newly emerging SARS-CoV-2. Through these practices, we got familiar with this brand-new virus and gained precious experiences of working on this emerging pathogen. We would like to further study this devastating virus and to provide more needed service for our research and industrial communities in order to develop useful detection kits, antiviral drugs and vaccines to control this global pandemic.



2019年底COVID-19病例出現,2020年疫情全球大爆發,中研院於2020年1月28日成立了一個因應COVID-19的工作小組,由廖院長指派Dr. 林宜玲負責協調工作。目前Dr. 林除了擔任中研院生醫所的P3實驗室主持人,也是生醫轉譯研究中心(BioTReC)新成立的“新興傳染病專題中心(Emerging Infectious Disease Division, EIDD)”首任執行長,並負責位於國家生技研究園區(NBRP)的傳染病核心設施(Infectious Disease Core Facility, ID Core)。因此,除了研究黃質病毒,SARS-CoV-2也成為我們的工作重心。我們已建立了各項病毒分析與檢測系統,來滿足為對抗COVID-19所研發產品的迫切抗病毒測試需求。我們協助中研院內和外部機構的研究人員進行抗病毒測定,也協助台灣廠商測試其產品的體外和體內抗病毒功效,其中兩家疫苗廠已獲准進行二期人體試驗,我們也繼續協助檢測其疫苗所誘發的抗SARS-CoV-2中和性抗體效價。


Dr. Lin, Yi-Ling
林宜玲 博士

Research Fellow
Division Chief

1992, PhD, University of California, Los Angeles (UCLA), USA 2020 ~ date, CEO, Emerging Infectious Disease Division (EIDD), Biomedical Translation Research Center (BioTReC), Academia Sinica   Contact Information:
  • TEL(lab):02-2789-9013 (Room No: 443)
  • 02-2652-3902
  • FAX:02-2785-8847

  • Molecular Virology
  • Viral Pathogenesis
  • Viral Immunology

NEWS 最新消息

  1. 〈研之有物〉COVID-19抗疫作戰的關鍵少數─中研院P3實驗室開箱

    Mar 30, 2021
  2. 2020.11.11中研講堂

    Nov 11, 2020



CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
Scientific Report , Apr 22, 2021
Preventive effects of folic acid on Zika virus-associated poor pregnancy outcomes in immunocompromised mice
PLOS Pathogens, May 11, 2020
Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections
Journal of Medicinal Chemistry, Feb 03, 2020